ergonovine has been researched along with clonidine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cools, A; Struyker Boudier, H; Teppema, L; Van Rossum, J | 1 |
| Ito, I; Kakihana, M; Noda, H; Ohtsuka, S; Sugishita, Y | 1 |
| Cools, AR; Oosterloo, SK | 1 |
| Ishizaka, H; Matsunaga, T; Okumura, K; Tsunoda, R; Yasue, H | 1 |
4 other study(ies) available for ergonovine and clonidine
| Article | Year |
|---|---|
(3,4-Dihydroxy-phenylamino)-2-imidazoline (DPI), a new potent agonist at dopamine receptors mediating neuronal inhibition.
Topics: Animals; Catecholamines; Clonidine; Dopamine; Ergonovine; Esophagus; Ganglia; Imidazoles; Neural Inhibition; Receptors, Drug; Snails | 1975 |
Significant role of alpha 2-adrenoceptors in coronary artery spasm.
Topics: Animals; Clonidine; Coronary Angiography; Coronary Vasospasm; Coronary Vessels; Dogs; Electrocardiography; Ergonovine; Female; Male; Methoxamine; Norepinephrine; Phentolamine; Receptors, Adrenergic, alpha; Vascular Resistance; Yohimbine | 1985 |
(3,4-Dihydroxyphenylimino)-2-imidazoline (DPI) and its action at noradrenergic and dopaminergic receptors in the nucleus accumbens of rats: mesolimbic catecholamine receptors and hyperactivity.
Topics: Animals; Catecholamines; Clonidine; Ergonovine; Humans; Hyperkinesis; Imidazolines; Male; Nucleus Accumbens; Phentolamine; Phenylephrine; Rats; Rats, Inbred Strains; Receptors, Adrenergic; Receptors, Dopamine; Septal Nuclei | 1983 |
Influence of inhibition of endothelium-derived nitric oxide formation to effects of vasoconstrictor agents neuropeptide Y, clonidine, and ergonovine on coronary vascular resistance.
Topics: Animals; Arginine; Blood Pressure; Clonidine; Coronary Circulation; Dogs; Ergonovine; Female; Heart Rate; Male; Neuropeptide Y; NG-Nitroarginine Methyl Ester; Nitric Oxide; Vascular Resistance; Vasoconstrictor Agents | 1994 |